was read the article
array:25 [ "pii" => "S2173580821000596" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2019.03.021" "estado" => "S300" "fechaPublicacion" => "2022-06-01" "aid" => "1306" "copyright" => "Sociedad Española de Neurología" "copyrightAnyo" => "2019" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Neurologia. 2022;37:362-70" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0213485319300568" "issn" => "02134853" "doi" => "10.1016/j.nrl.2019.03.008" "estado" => "S300" "fechaPublicacion" => "2022-06-01" "aid" => "1306" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Neurologia. 2022;37:362-70" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 655 "formatos" => array:3 [ "EPUB" => 43 "HTML" => 211 "PDF" => 401 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Infarto cerebral embólico de origen no determinado: más allá de la fibrilación auricular" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "362" "paginaFinal" => "370" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Embolic stroke of undetermined source: Beyond atrial fibrillation" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2540 "Ancho" => 2500 "Tamanyo" => 481638 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Bloqueos interauriculares.</p> <p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Panel A: bloqueo interauricular parcial (onda P<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>120<span class="elsevierStyleHsp" style=""></span>ms).</p> <p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Panel B: bloqueo interauricular avanzado (onda P<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>120<span class="elsevierStyleHsp" style=""></span>ms<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>morfología bifásica en la cara inferior: derivaciones <span class="elsevierStyleSmallCaps">ii</span>, <span class="elsevierStyleSmallCaps">iii</span> y aVF).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Arauz, C. Arteaga, C. Zapata-Gómez, C. Ramos-Ventura, B. Méndez, R. Otiniano-Sifuentes, S. Haseeb, R. González-Oscoy, A. Baranchuk" "autores" => array:9 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Arauz" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Arteaga" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Zapata-Gómez" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Ramos-Ventura" ] 4 => array:2 [ "nombre" => "B." "apellidos" => "Méndez" ] 5 => array:2 [ "nombre" => "R." "apellidos" => "Otiniano-Sifuentes" ] 6 => array:2 [ "nombre" => "S." "apellidos" => "Haseeb" ] 7 => array:2 [ "nombre" => "R." "apellidos" => "González-Oscoy" ] 8 => array:2 [ "nombre" => "A." "apellidos" => "Baranchuk" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173580821000596" "doi" => "10.1016/j.nrleng.2019.03.021" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580821000596?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485319300568?idApp=UINPBA00004N" "url" => "/02134853/0000003700000005/v1_202205210936/S0213485319300568/v1_202205210936/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S217358082030095X" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2020.05.007" "estado" => "S300" "fechaPublicacion" => "2022-06-01" "aid" => "1240" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Neurologia. 2022;37:371-82" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Changes in the choroid plexuses and brain barriers associated with high blood pressure and ageing" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "371" "paginaFinal" => "382" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Variaciones de los plexos coroideos y las barreras cerebrales en la hipertensión arterial y el envejecimiento" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1514 "Ancho" => 1417 "Tamanyo" => 168911 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Diagram of the brain barriers and potential biomarkers of their disruption. BBB: blood–brain barrier; BCSFB: blood–CSF barrier; ChP: choroid plexus; CSF: cerebrospinal fluid; SAS: subarachnoid space; S100β: S100 calcium-binding protein B (low serum concentration).</p> <p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Squares: disruption of the blood–brain barrier by S100β; circles: disruption of the blood–cerebrospinal fluid barrier by monomeric transthyretin.</p> <p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Source: González-Marrero et al.,<a class="elsevierStyleCrossRef" href="#bib1005"><span class="elsevierStyleSup">94</span></a> Al-Sarraf and Philip,<a class="elsevierStyleCrossRef" href="#bib1035"><span class="elsevierStyleSup">100</span></a> Marchi et al.<a class="elsevierStyleCrossRef" href="#bib1050"><span class="elsevierStyleSup">103</span></a>.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "I. Gonzalez-Marrero, L.G. Hernández-Abad, L. Castañeyra-Ruiz, E.M. Carmona-Calero, A. Castañeyra-Perdomo" "autores" => array:5 [ 0 => array:2 [ "nombre" => "I." "apellidos" => "Gonzalez-Marrero" ] 1 => array:2 [ "nombre" => "L.G." "apellidos" => "Hernández-Abad" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Castañeyra-Ruiz" ] 3 => array:2 [ "nombre" => "E.M." "apellidos" => "Carmona-Calero" ] 4 => array:2 [ "nombre" => "A." "apellidos" => "Castañeyra-Perdomo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213485318301750" "doi" => "10.1016/j.nrl.2018.06.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485318301750?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217358082030095X?idApp=UINPBA00004N" "url" => "/21735808/0000003700000005/v1_202206050515/S217358082030095X/v1_202206050515/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2173580821000602" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2019.03.022" "estado" => "S300" "fechaPublicacion" => "2022-06-01" "aid" => "1307" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Neurologia. 2022;37:355-61" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Attention to acute cerebrovascular disease in Guipúzcoa: description of the results of a reference hospital in a centralized care model" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "355" "paginaFinal" => "361" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Atención a la enfermedad cerebrovascular aguda en Guipúzcoa: descripción de los resultados de un hospital de referencia en un modelo de atención centralizado" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1274 "Ancho" => 2518 "Tamanyo" => 148281 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A) Overall mortality due to acute stroke (absolute numbers) at discharge and at 12 months. B) Percentage of deceased patients by diagnosis. C) Disability (as measured by the modified Rankin Scale) at admission, at discharge, and at 12 months, only for patients for whom data were available for all 3 variables (n = 488).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "G. Fernández-Eulate, P. Arocena, A. Muñoz-Lopetegi, J. Rodriguez-Antigüedad, D. Campo-Caballero, J. Equiza, N. Andrés, A. de Arce, F. Gonzalez, N. Diez, J. Basterrechea, E. Suquia, P. de la Riva, M. Martinez-Zabaleta" "autores" => array:14 [ 0 => array:2 [ "nombre" => "G." "apellidos" => "Fernández-Eulate" ] 1 => array:2 [ "nombre" => "P." "apellidos" => "Arocena" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Muñoz-Lopetegi" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Rodriguez-Antigüedad" ] 4 => array:2 [ "nombre" => "D." "apellidos" => "Campo-Caballero" ] 5 => array:2 [ "nombre" => "J." "apellidos" => "Equiza" ] 6 => array:2 [ "nombre" => "N." "apellidos" => "Andrés" ] 7 => array:2 [ "nombre" => "A." "apellidos" => "de Arce" ] 8 => array:2 [ "nombre" => "F." "apellidos" => "Gonzalez" ] 9 => array:2 [ "nombre" => "N." "apellidos" => "Diez" ] 10 => array:2 [ "nombre" => "J." "apellidos" => "Basterrechea" ] 11 => array:2 [ "nombre" => "E." "apellidos" => "Suquia" ] 12 => array:2 [ "nombre" => "P." "apellidos" => "de la Riva" ] 13 => array:2 [ "nombre" => "M." "apellidos" => "Martinez-Zabaleta" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S021348531930057X" "doi" => "10.1016/j.nrl.2019.03.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021348531930057X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580821000602?idApp=UINPBA00004N" "url" => "/21735808/0000003700000005/v1_202206050515/S2173580821000602/v1_202206050515/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Embolic stroke of undetermined source: beyond atrial fibrillation" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "362" "paginaFinal" => "370" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Arauz, C. Arteaga, C. Zapata-Gómez, C. Ramos-Ventura, B. Méndez, R. Otiniano-Sifuentes, S. Haseeb, R. González-Oscoy, A. Baranchuk" "autores" => array:9 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "Arauz" "email" => array:1 [ 0 => "Antonio.arauz@prodigy.net.mx" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "C." "apellidos" => "Arteaga" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "C." "apellidos" => "Zapata-Gómez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "C." "apellidos" => "Ramos-Ventura" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "B." "apellidos" => "Méndez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "R." "apellidos" => "Otiniano-Sifuentes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 6 => array:3 [ "nombre" => "S." "apellidos" => "Haseeb" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 7 => array:3 [ "nombre" => "R." "apellidos" => "González-Oscoy" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 8 => array:3 [ "nombre" => "A." "apellidos" => "Baranchuk" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Clínica de Enfermedad Vascular Cerebral, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Ciudad de México, Mexico" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Queen's University, Kingston, Ontario, Canada" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Infarto cerebral embólico de origen no determinado: más allá de la fibrilación auricular" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2126 "Ancho" => 2167 "Tamanyo" => 438194 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Interatrial blocks (IAB). (A) Partial interatrial block (P-wave > 120<span class="elsevierStyleHsp" style=""></span>ms). (B) Advanced interatrial block (P-wave > 120<span class="elsevierStyleHsp" style=""></span>ms<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>biphasic morphology in leads II, III, and aVF).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Up to 25% of all strokes are of unknown cause (cryptogenic). Most cases are of emboligenic origin, although the source cannot be determined. The concept of “embolic stroke of undetermined source” (ESUS) includes non-lacunar strokes, which present clinical and radiological characteristics suggestive of stroke but lack a clear cardioembolic source (<a class="elsevierStyleCrossRefs" href="#tbl0005">Tables 1 and 2</a>).<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">1</span></a> Up to 30% of ESUS are associated with paroxysmal atrial fibrillation (AF), but the cause of stroke or association with AF cannot be confirmed in the remaining cases.<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">2,3</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">ESUS was first described in 2014. Since then, several series have reported frequencies ranging from 9% to 25% (mean, 17%) of all strokes. ESUS presents at a mean age of 65 years, is more common in men (60%), and is less frequently associated with the classic vascular risk factors. This type of stroke is less severe (median NIHSS score of 5) and is associated with a recurrence rate of 4.5% at 2–3 years of follow-up. Most patients with ESUS are treated with antiplatelets.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">This suggests that ESUS may be caused by cardioembolic mechanisms; the failure to detect AF in these patients may underscore the need to search for other predictors or change the way in which AF is detected.<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">5</span></a> Secondary prevention strategies should also be reinforced, given that patients with ESUS are younger and present less severe episodes. This review aims to analyse the available evidence on atrial cardiopathy, its role in the pathogenesis of ESUS, its potential therapeutic implications, and its identification with electrocardiographic, echocardiographic, and serum markers.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Embolic stroke of undetermined source. Clinical and neuroimaging characteristics</span><p id="par0020" class="elsevierStylePara elsevierViewall">The clinical and radiological characteristics of ESUS are similar to those of cardioembolic stroke. In a series of 275 patients with ESUS, 74% presented severe neurological impairment at stroke onset, and neuroimaging studies revealed predominantly cortical ischaemic lesions or multiple cortical-subcortical ischaemic lesions in different arterial territories, with early recanalisation and haemorrhagic transformation.<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">6</span></a> ESUS and cardioembolic stroke also present similar recurrence rates, although ESUS is associated with lower long-term mortality rates, probably due to the lower severity of this type of stroke.<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">6–8</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Age and CHADS<span class="elsevierStyleInf">2</span> and CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc scale scores seem to be the most useful predictors of ESUS. Compared to patients younger than 60 years, the risk of recurrence is 3 times higher and the mortality rate is 8 times higher in individuals older than 80 years.<a class="elsevierStyleCrossRefs" href="#bib0395"><span class="elsevierStyleSup">9,10</span></a> High-risk patients (according to CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc scores) present a three-fold increase in the risk of recurrence and a thirteen-fold increase in the risk of death, compared to low-risk patients.<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">11</span></a></p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Embolic stroke of undetermined source and atrial fibrillation</span><p id="par0030" class="elsevierStylePara elsevierViewall">Systematic screening for AF has considerable therapeutic implications: in the absence of AF or a clear cardioembolic source, current treatment guidelines recommend antiplatelets, whereas patients with AF or other potential sources of cardiac embolism should receive oral anticoagulants.<a class="elsevierStyleCrossRefs" href="#bib0410"><span class="elsevierStyleSup">12–14</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">A clear association has been found between duration of cardiac monitoring and detection of AF.<a class="elsevierStyleCrossRef" href="#bib0425"><span class="elsevierStyleSup">15</span></a> Detection rates are 3% for admission ECG, 5%-8% for inpatient continuous telemetry, 3%-6% for 24-48 hours Holter monitoring, 16% for mobile continuous outpatient telemetry, and 30% for implantable loop recorders (ILR).<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">2,3,16</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">In the CRYSTAL-AF study, AF was detected in 8.9% of patients with ILRs, compared to 1.4% of patients undergoing standard ECG studies (HR: 6.4; 95% CI, 1.9-21.7; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001). The detection rate increased to 12.4% in the group of patients with ILRs when monitoring was continued for 12 months (HR: 7.3; 95% CI, 2.6-20.8; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001).<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">2</span></a> The EMBRACE study randomised 572 patients with cryptogenic stroke or transient ischaemic attack (TIA) in the previous 6 months, and no known history of AF, to undergo either 30-day non-invasive cardiac monitoring (intervention group) or conventional 24-hour Holter monitoring (control group). AF lasting ≥30<span class="elsevierStyleHsp" style=""></span>seconds was detected in 16.1% of patients in the intervention group and 3.2% of controls (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001). The number needed to screen was 8 for detecting a new case of AF. Furthermore, AF lasting ≥ 2.5<span class="elsevierStyleHsp" style=""></span>minutes was detected in 9.9% of patients in the intervention group and 2.5% of controls (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001).<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">3</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Atrial cardiopathy</span><p id="par0045" class="elsevierStylePara elsevierViewall">The lack of evidence on a temporal association between AF and ESUS, despite multiple cardiac monitoring studies,<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">17</span></a> has led researchers to reconsider the nature of this relationship and suggests that left atrial cardiopathy may be the cause of stroke, independently of AF.<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">18,19</span></a> Atrial cardiopathy increases the risk of AF and stroke in patients with no known history of AF and showing sinus rhythm on different studies (ECG, Holter and events monitors, etc). Markers of left atrial dysfunction can be classified into 3 groups: electrocardiographic markers (P-wave terminal force in lead V1, episodes of subclinical atrial tachyarrhythmia, atrial extrasystoles, interatrial block),<a class="elsevierStyleCrossRefs" href="#bib0445"><span class="elsevierStyleSup">19–24</span></a> echocardiographic markers (left atrial size, volume, and/or function),<a class="elsevierStyleCrossRefs" href="#bib0475"><span class="elsevierStyleSup">25–27</span></a> and biochemical markers (cardiac troponin, NT-proBNP, von Willebrand factor).<a class="elsevierStyleCrossRefs" href="#bib0490"><span class="elsevierStyleSup">28–31</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Atrial cardiopathy may cause thromboembolism before AF occurs; therefore, the latter should not be considered a necessary condition for stroke, but rather a common manifestation of an underlying atrial cardiopathy. In the light of the above, studying atrial cardiopathy may provide useful data about the pathophysiological mechanisms of ESUS and help improve secondary prevention.<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">18,32,34</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Electrocardiographic markers of atrial cardiopathy</span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">P-wave terminal force in lead V1</span><p id="par0055" class="elsevierStylePara elsevierViewall">P-wave terminal force in lead V1 (PTFV1) measures electric conduction through the atria. It was described by Morris et al.<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">21</span></a> as an electrocardiographic sign of left atrial involvement. Prolonged PTFV1 reflects left atrial changes that alter electric conduction due to left ventricular fibrosis, hypertrophy, or increased left ventricular filling pressure.<a class="elsevierStyleCrossRef" href="#bib0525"><span class="elsevierStyleSup">35</span></a> Prolonged PTFV1 has been proposed as a predictor of AF.<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">22</span></a> Prolonged PTFV1 reveals underlying atrial cardiopathy, which may predispose to embolic events, even in the absence of AF.<a class="elsevierStyleCrossRefs" href="#bib0445"><span class="elsevierStyleSup">19,23,33,36</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Episodes of subclinical atrial tachyarrhythmia</span><p id="par0060" class="elsevierStylePara elsevierViewall">A subanalysis of the ASSERT trial evaluated the significance of episodes of subclinical atrial tachyarrhythmia (SATa) detected by ILRs; these were defined as episodes of atrial rate > 190 beats per minute for more than 6<span class="elsevierStyleHsp" style=""></span>minutes. SATa was associated with increased risk of clinical AF (HR: 5.56; 95% CI, 3.78-8.17; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001) and of stroke or systemic embolism (HR: 2.49; 95% CI, 1.28-4.85; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.007) during the first 3 months of monitoring, compared to patients without SATa. Furthermore, in the time-dependent analysis, which compared all episodes of SATa lasting > 6<span class="elsevierStyleHsp" style=""></span>minutes against patients without SATa, SATa was associated with increased risk of stroke or systemic embolism (HR: 1.76; 95% CI, 0.99-3.11; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.05).<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">20</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">Using data from the TRENDS study,<a class="elsevierStyleCrossRef" href="#bib0535"><span class="elsevierStyleSup">37</span></a> Ziegler et al.<a class="elsevierStyleCrossRef" href="#bib0540"><span class="elsevierStyleSup">38</span></a> analysed the incidence of AF in 1368 patients with ILRs and no history of AF, stroke, or TIA. The researchers found an incidence of 30% (atrial tachycardia/AF > 5<span class="elsevierStyleHsp" style=""></span>minutes on any day) during a mean follow-up period (SD) of 1.1 years (0.7), regardless of stroke risk factors as measured by the CHADS<span class="elsevierStyleInf">2</span>. An analysis of the association between stroke risk factors and atrial tachycardia/AF > 6<span class="elsevierStyleHsp" style=""></span>hours found a significant increase in the incidence of AF (12%, 15%, and 18% in patients with intermediate, high, and very high risk of stroke, respectively; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.04). Daoud et al.<a class="elsevierStyleCrossRef" href="#bib0545"><span class="elsevierStyleSup">39</span></a> analysed a subgroup of patients from the TRENDS study,<a class="elsevierStyleCrossRef" href="#bib0535"><span class="elsevierStyleSup">37</span></a> and concluded that the temporal association between stroke or systemic embolism in patients with ILRs may involve cardioembolic mechanisms other than AF.</p><p id="par0070" class="elsevierStylePara elsevierViewall">In patients with ESUS, SATa is associated with increased risk of thromboembolism. However, the association between SATa and risk of stroke recurrence is yet to be determined, and no precise indications for anticoagulation treatment have been established for these patients.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Bayés syndrome</span><p id="par0075" class="elsevierStylePara elsevierViewall">Bayés syndrome is characterised by the copresence of supraventricular arrhythmia, particularly AF, and interatrial block (IAB). Bayés et al.<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">24</span></a> classified IAB as partial, when the P-wave has a duration of ≥ 120<span class="elsevierStyleHsp" style=""></span>ms and presents a negative mode, and advanced, when the P-wave has a duration of ≥ 120<span class="elsevierStyleHsp" style=""></span>ms and presents a biphasic morphology in leads II, III, and aVF, resulting from caudocranial activation of the left atrium (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Agarwal et al.<a class="elsevierStyleCrossRef" href="#bib0550"><span class="elsevierStyleSup">40</span></a> followed up 308 patients with AF and 308 patients with sinus rhythm for a mean (SD) of 16 months (23), and finding advanced IAB in 52% and 18%, respectively.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">In a sample of 32 patients with advanced IAB, Bayés et al.<a class="elsevierStyleCrossRef" href="#bib0555"><span class="elsevierStyleSup">41</span></a> also observed a significant decrease in the incidence of supraventricular arrhythmia in patients receiving antiarrhythmic treatment for 18 months (93.7%, vs 25% in controls). An association has been observed between advanced IAB and recurrence of AF a year after pharmacological cardioversion (OR: 18.4, regardless of the antiarrhythmic drug used).<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">42</span></a> Furthermore, presence of advanced IAB prior to pulmonary vein isolation is associated with increased risk of recurrence of AF after the procedure.<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">43</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Advanced IAB is a predictor of high risk for new-onset AF after successful cavotricuspid isthmus ablation in patients with typical atrial flutter,<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">44</span></a> and an independent predictor of new-onset AF in patients with severe congestive heart failure following cardiac resynchronisation therapy.<a class="elsevierStyleCrossRef" href="#bib0575"><span class="elsevierStyleSup">45</span></a> Advanced IAB may occur in different clinical scenarios, including atrial dilation and old age (it is considered a degenerative process, with a prevalence of 5.4% among patients < 20 years, vs 60% in patients > 50 years),<a class="elsevierStyleCrossRefs" href="#bib0565"><span class="elsevierStyleSup">43,44,46,47</span></a> diabetes, obstructive sleep apnoea syndrome, and metabolic syndrome.<a class="elsevierStyleCrossRef" href="#bib0590"><span class="elsevierStyleSup">48</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">Presence of advanced IAB supports the hypothesis of left atrial dysfunction as an independent risk factor for stroke<a class="elsevierStyleCrossRef" href="#bib0595"><span class="elsevierStyleSup">49</span></a>; early diagnosis of Bayés syndrome is therefore essential, since these patients will probably need preventive antiarrhythmic and antithrombotic therapy.<a class="elsevierStyleCrossRef" href="#bib0585"><span class="elsevierStyleSup">47</span></a></p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Echocardiographic markers</span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Morphology of the left atrial appendage</span><p id="par0095" class="elsevierStylePara elsevierViewall">The left atrial appendage (LAA) is an embryonic remnant of the primordial left atrium that acts as a reservoir during conditions of fluid overload.<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">25</span></a> It is the main source of cardiac thrombi in patients with AF, due to the blood stasis caused by its morphology.<a class="elsevierStyleCrossRef" href="#bib0600"><span class="elsevierStyleSup">50</span></a> Manning et al.<a class="elsevierStyleCrossRef" href="#bib0605"><span class="elsevierStyleSup">51</span></a> found that up to 98% of all atrial thrombi formed during AF originated in the LAA. In a multicentre retrospective study of 359 patients with AF undergoing brain and cardiac MRI studies, Anselmino et al.<a class="elsevierStyleCrossRef" href="#bib0600"><span class="elsevierStyleSup">50</span></a> classified LAA morphology into 4 types: chicken wing, cauliflower, cactus, and wind sock. Silent cerebral ischaemic lesions were detected in 295 patients (84.8%), with a median of 23 lesions. The population under study was stratified by quartiles according to the number of lesions: ≤ 6, 7-23, 24-43, and ≥ 44. An association was found between the number of silent cerebral ischaemic lesions and LAA morphology. Cauliflower morphology has been associated with greater numbers of lesions.<a class="elsevierStyleCrossRefs" href="#bib0480"><span class="elsevierStyleSup">26,50</span></a> Similarly, Di Biase et al.<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">25</span></a> found that chicken-wing LAAs are associated with a 79% reduction in the risk of stroke or TIA (OR: 0.21, 95% CI, 0.05-0.91; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.036).</p><p id="par0100" class="elsevierStylePara elsevierViewall">Previous studies suggest that non-chicken-wing LAA may increase the risk of embolic events in patients with ESUS, constituting an echocardiographic marker of risk of recurrence.<a class="elsevierStyleCrossRefs" href="#bib0475"><span class="elsevierStyleSup">25,26</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Left atrial size</span><p id="par0105" class="elsevierStylePara elsevierViewall">Greater left atrial size is associated with embolic events, regardless of presence of AF. In a study of 64 patients with AF undergoing transthoracic and transoesophageal echocardiography studies, Radwan<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">27</span></a> found that indexed left atrial anteroposterior diameter (cut-off: 3<span class="elsevierStyleHsp" style=""></span>cm/m<span class="elsevierStyleSup">2</span>; OR: 7.5, 95% CI, 1.24-45.2; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.02) and indexed left atrial ellipsoid volume (cut-off: 42<span class="elsevierStyleHsp" style=""></span>cm<span class="elsevierStyleSup">3</span>/m<span class="elsevierStyleSup">2</span>; OR: 6.5; 95% CI, 1.32-32.07; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.02) were the most reliable predictors of thromboembolic risk. Furthermore, greater percentages of left atrial fibrosis have also been associated with greater risk of thromboembolism and stroke.<a class="elsevierStyleCrossRef" href="#bib0610"><span class="elsevierStyleSup">52</span></a></p></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Serum biomarkers</span><p id="par0110" class="elsevierStylePara elsevierViewall">Biomarkers of cardioembolism focus on the systemic and atrial basis of the disease. Each biomarker has shown an association with risk of embolic stroke regardless of the presence of AF. We summarise the available evidence on the currently available biomarkers of atrial cardiopathy.</p><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Cardiac troponin</span><p id="par0115" class="elsevierStylePara elsevierViewall">Cardiac troponin levels are elevated in patients with clinical and subclinical myocardial lesions and structural heart disease.<a class="elsevierStyleCrossRef" href="#bib0615"><span class="elsevierStyleSup">53</span></a> Between 5% and 34% of patients with stroke present elevated cardiac troponin levels but no typical symptoms or electrocardiographic evidence of acute coronary ischaemia.<a class="elsevierStyleCrossRefs" href="#bib0620"><span class="elsevierStyleSup">54,55</span></a> The TRELAS study found that 24% of patients with stroke and elevated cardiac troponin levels presented coronary lesions that were responsible for either myocardial ischaemia or cardioembolism, suggesting different causes of cardiac troponin elevation in stroke.<a class="elsevierStyleCrossRef" href="#bib0630"><span class="elsevierStyleSup">56</span></a> An association has also been observed between elevated cardiac troponin levels and cardioembolic stroke and ESUS.<a class="elsevierStyleCrossRefs" href="#bib0490"><span class="elsevierStyleSup">28,29</span></a></p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">N-terminal pro-brain natriuretic peptide</span><p id="par0120" class="elsevierStylePara elsevierViewall">N-terminal pro-brain natriuretic peptide (NT-proBNP) is another serum biomarker of heart disease.<a class="elsevierStyleCrossRef" href="#bib0635"><span class="elsevierStyleSup">57</span></a> Elevated NT-proBNP levels are associated with greater likelihood of detecting AF during the follow-up of patients with cryptogenic<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">30</span></a> and cardioembolic stroke.<a class="elsevierStyleCrossRefs" href="#bib0640"><span class="elsevierStyleSup">58–60</span></a> In a study by Li et al.,<a class="elsevierStyleCrossRef" href="#bib0655"><span class="elsevierStyleSup">61</span></a> elevated cardiac troponin and NT-proBNP levels resulted in a three-fold increase in the risk of cardioembolic stroke; the association was stronger for NT-proBNP.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Von Willebrand factor</span><p id="par0125" class="elsevierStylePara elsevierViewall">Von Willebrand factor (vWF) plays a major role in thrombus formation. A correlation has been observed between elevated plasma vWF levels and risk of atherosclerosis or thrombosis in patients with coronary heart disease; vWF level is therefore considered a marker of endothelial dysfunction.<a class="elsevierStyleCrossRef" href="#bib0660"><span class="elsevierStyleSup">62</span></a> Some studies have demonstrated an association between high vWF levels and increased risk of stroke, particularly cardioembolic and cryptogenic stroke,<a class="elsevierStyleCrossRefs" href="#bib0665"><span class="elsevierStyleSup">63–65</span></a> which suggests that the prothrombotic effects of vWF are independent of other markers of atherosclerosis/inflammation or endothelial damage.<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">31</span></a> However, evidence is scarce and the pathogenic mechanism seems to differ from that of atrial cardiopathy.</p></span></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">New treatment approaches</span><p id="par0130" class="elsevierStylePara elsevierViewall">The optimal treatment of patients with ESUS has not been established; at present, most of them are treated with antiplatelet drugs. The benefits of anticoagulants in patients with no evidence of AF are unclear, although several controlled clinical trials have been conducted. Whereas empirical anticoagulation seems a reasonable approach in patients with recurrent ESUS, secondary prevention in the remaining cases includes blood pressure control, statins, lifestyle changes, and antiplatelet treatment.<a class="elsevierStyleCrossRefs" href="#bib0450"><span class="elsevierStyleSup">20,66</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">Several clinical trials have analysed whether direct oral anticoagulants reduce the risk of recurrence; 2 have concluded and another one is currently underway. The NAVIGATE ESUS trial<a class="elsevierStyleCrossRef" href="#bib0685"><span class="elsevierStyleSup">67</span></a> compared 15<span class="elsevierStyleHsp" style=""></span>mg rivaroxaban against 100<span class="elsevierStyleHsp" style=""></span>mg aspirin, whereas the RE-SPECT ESUS trial<a class="elsevierStyleCrossRef" href="#bib0690"><span class="elsevierStyleSup">68</span></a> compared 2 doses of dabigatran (110 and 150<span class="elsevierStyleHsp" style=""></span>mg twice daily) against aspirin. Both treatment approaches failed to reduce recurrence rates, and rivaroxaban was associated with increased risk of haemorrhage.<a class="elsevierStyleCrossRef" href="#bib0685"><span class="elsevierStyleSup">67</span></a> However, in the NAVIGATE ESUS trial, both treatment groups showed a recurrence rate of 5% per year, which confirms the need for better patient selection and better treatment options. Some of the electrocardiographic, echocardiographic, and biochemical markers addressed in this review may be useful in identifying patients with ESUS and high risk of recurrence. The ARCADIA trial,<a class="elsevierStyleCrossRef" href="#bib0695"><span class="elsevierStyleSup">69</span></a> which is currently underway, compares 5<span class="elsevierStyleHsp" style=""></span>mg apixaban against 81<span class="elsevierStyleHsp" style=""></span>mg aspirin/day in patients aged ≥ 45 years with ESUS and evidence of atrial cardiopathy. The trial aims to demonstrate the efficacy and safety of apixaban for the secondary prevention of stroke at 4 years of follow-up; results are expected in 2022. Until further evidence is published, anticoagulation should be used with caution in patients with ESUS presenting high risk of AF and recurrence.</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Conclusions</span><p id="par0140" class="elsevierStylePara elsevierViewall">The available evidence suggests that the left atrium plays a major role in stroke pathogenesis and prevention. Rather than focusing on AF only, we should consider atrial cardiopathy in general as a cause of stroke. In fact, AF is very likely to result from a more complex underlying heart disease.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Systematically searching for risk factors, especially P-wave morphology and duration on ECG, atrial extrasystoles, LAA morphology on echocardiogram, and such biomarkers as NT-proBNP, may be valuable in detecting patients with ESUS and high risk of recurrence.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:14 [ 0 => array:3 [ "identificador" => "xres1726021" "titulo" => "Abstract" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Development" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1524394" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1726022" "titulo" => "Resumen" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Desarrollo" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1524393" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Embolic stroke of undetermined source. Clinical and neuroimaging characteristics" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Embolic stroke of undetermined source and atrial fibrillation" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Atrial cardiopathy" ] 8 => array:3 [ "identificador" => "sec0025" "titulo" => "Electrocardiographic markers of atrial cardiopathy" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0030" "titulo" => "P-wave terminal force in lead V1" ] 1 => array:2 [ "identificador" => "sec0035" "titulo" => "Episodes of subclinical atrial tachyarrhythmia" ] 2 => array:2 [ "identificador" => "sec0040" "titulo" => "Bayés syndrome" ] ] ] 9 => array:3 [ "identificador" => "sec0045" "titulo" => "Echocardiographic markers" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0050" "titulo" => "Morphology of the left atrial appendage" ] 1 => array:2 [ "identificador" => "sec0055" "titulo" => "Left atrial size" ] ] ] 10 => array:3 [ "identificador" => "sec0060" "titulo" => "Serum biomarkers" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "Cardiac troponin" ] 1 => array:2 [ "identificador" => "sec0070" "titulo" => "N-terminal pro-brain natriuretic peptide" ] 2 => array:2 [ "identificador" => "sec0075" "titulo" => "Von Willebrand factor" ] ] ] 11 => array:2 [ "identificador" => "sec0080" "titulo" => "New treatment approaches" ] 12 => array:2 [ "identificador" => "sec0085" "titulo" => "Conclusions" ] 13 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2018-11-27" "fechaAceptado" => "2019-03-03" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1524394" "palabras" => array:3 [ 0 => "Embolic stroke of undetermined source" 1 => "Atrial cardiopathy" 2 => "Recurrence" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1524393" "palabras" => array:3 [ 0 => "Infarto cerebral embólico de origen no determinado" 1 => "Cardiopatía atrial" 2 => "Recurrencia" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Embolic stroke of undetermined source (ESUS) accounts for 25% of all cerebral infarcts; only 30% are associated with paroxysmal atrial fibrillation (AF). Various biochemical, electrocardiographic, and echocardiographic findings may suggest left atrial damage and increased risk of embolism in the absence of clinically documented AF or atrial flutter. In this review, we analyse the available evidence on atrial cardiopathy or atrial disease, its involvement in ESUS, and its identification through electrocardiographic, echocardiographic, and serum markers and its possible therapeutic implications.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Development</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A systematic search was conducted on MEDLINE (PubMed) using the following MeSH terms: MeSH [ESUS]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[atrial cardiopathy]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[atrial fibrillation]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[interatrial block]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[treatment]. We selected what we considered to be the most useful original prospective or retrospective studies and systematic reviews. We then read the full texts of the articles and checked the references cited in each article.</p><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">We analyse epidemiological and demographic variables of patients with ESUS, as well as recent evidence related to presentation and prognosis and factors associated with recurrence and mortality. We review the contribution of atrial cardiopathy diagnosis prior to the detection of AF and the clinical, electrocardiographic, and echocardiographic variables and the biochemical markers associated with its development and its potential contribution to cerebral embolism.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The systematic search of biochemical and electrocardiographic, and echocardiographic alterations can be useful to identify ESUS patients at higher risk of recurrence.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Development" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Introducción</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">El infarto cerebral embólico de origen no determinado (ESUS por sus siglas en inglés) representa el 25% de todos los infartos cerebrales y solo el 30% se asocia con fibrilación auricular (FA) paroxística. Existen diferentes hallazgos bioquímicos, electro y ecocardiográficos que sugieren daño auricular izquierdo y aumento del riesgo de embolismo en ausencia de FA o <span class="elsevierStyleItalic">flutter</span> auricular clínicamente documentados. En la presente revisión analizamos la evidencia disponible sobre cardiopatía atrial o enfermedad auricular, su implicación en el ESUS y su identificación mediante marcadores electrocardiográficos, ecocardiográficos y séricos y sus posibles implicaciones terapéuticas.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Desarrollo</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se realizó una búsqueda sistematizada a través de la fuente de información MEDLINE (PubMed), utilizando una estrategia diseñada con términos MeSH [ESUS]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[atrial cardiopathy]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[atrial fibrillation]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[interatrial block]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[treatment]. Se seleccionaron las publicaciones originales de estudios prospectivos, retrospectivos y de revisión consideradas como las más útiles. Se procedió a la lectura del texto completo y la bibliografía aportada en cada artículo.</p><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Se incluyeron los factores epidemiológicos y demográficos de los pacientes ESUS, así como la evidencia reciente relacionada con su forma de presentación, pronóstico y factores asociados con recurrencia y mortalidad. Se revisó la contribución de la presencia de cardiopatía auricular previo a la documentación de FA y las variables clínicas, electro y ecocardiográficas, así como los marcadores bioquímicos asociados con su desarrollo y su contribución como fuente potencial de embolismo cerebral.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">La búsqueda sistemática de alteraciones bioquímicas, electro y ecocardiográficas pueden ser de utilidad para identificar pacientes ESUS con mayor riesgo de recurrencia.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Desarrollo" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "⋆" "nota" => "<p class="elsevierStyleNotepara" id="npar0020">Please cite this article as: Arauz A, Arteaga C, Zapata-Gómez C, Ramos-Ventura C, Méndez B, Otiniano-Sifuentes R, et al. Infarto cerebral embólico de origen no determinado: más allá de la fibrilación auricular. Neurología. 2022;37:362–370.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2126 "Ancho" => 2167 "Tamanyo" => 438194 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Interatrial blocks (IAB). (A) Partial interatrial block (P-wave > 120<span class="elsevierStyleHsp" style=""></span>ms). (B) Advanced interatrial block (P-wave > 120<span class="elsevierStyleHsp" style=""></span>ms<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>biphasic morphology in leads II, III, and aVF).</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">CT: computed tomography; MRI: magnetic resonance imaging.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1. Non-lacunar stroke detected by CT or MRI<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2. Absence of extracranial or intracranial atherosclerosis causing ≥ 50% luminal stenosis in arteries supplying the area of ischaemia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3. No major-risk cardioembolic source of embolism<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4. No other specific cause of stroke identified (eg, arteritis, dissection, migraine/vasospasm, drug abuse) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2929040.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Lacunar stroke is defined as a subcortical infarct ≤1.5 cm (≤ 2.0<span class="elsevierStyleHsp" style=""></span>cm on MRI diffusion images) in largest dimension, including on MRI diffusion-weighted images, and in the distribution of the small, penetrating cerebral arteries. Visualisation by CT usually requires delayed imaging > 24-48<span class="elsevierStyleHsp" style=""></span>hours after stroke onset.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Cardioembolic sources include permanent or paroxysmal atrial fibrillation, sustained atrial flutter, intracardiac thrombus, prosthetic cardiac valve, atrial myxoma or other cardiac tumours, mitral stenosis, recent (< 4 weeks) myocardial infarction, left ventricular ejection fraction < 30%, valvular vegetations, or infective endocarditis.</p> <p class="elsevierStyleNotepara" id="npar0015">Source: Hart et al.,<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">1</span></a> Hart et al.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">4</span></a></p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Diagnostic criteria for embolic stroke of undetermined source.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">CT: computed tomography; ECG: electrocardiography; MRI: magnetic resonance imaging.</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Source: Hart et al.,<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">1</span></a> Diener et al.<a class="elsevierStyleCrossRef" href="#bib0700"><span class="elsevierStyleSup">70</span></a></p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Brain CT or MRI \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12-lead ECG \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Transthoracic and transoesophageal echocardiography \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cardiac monitoring for ≥24<span class="elsevierStyleHsp" style=""></span>hours \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Imaging of both the extracranial and intracranial arteries supplying the area of brain ischaemia (catheter, MRI, or CT angiography, or cervical duplex plus transcranial Doppler ultrasonography) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2929041.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Diagnostic assessment of embolic stroke of undetermined source.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:70 [ 0 => array:3 [ "identificador" => "bib0355" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Embolic strokes of undetermined source: the case for a new clinical construct" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.G. Hart" 1 => "H.C. Diener" 2 => "S.B. Coutts" 3 => "J.D. Easton" 4 => "C.B. Granger" 5 => "M.J. O’Donnell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1474-4422(13)70310-7" "Revista" => array:6 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2014" "volumen" => "13" "paginaInicial" => "429" "paginaFinal" => "438" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24646875" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0360" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cryptogenic stroke and underlying atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Sanna" 1 => "H.C. Diener" 2 => "R.S. Passman" 3 => "V. Di Lazzaro" 4 => "R.A. Bernstein" 5 => "C.A. Morillo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1313600" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2014" "volumen" => "370" "paginaInicial" => "2478" "paginaFinal" => "2486" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24963567" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0365" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atrial fibrillation in patients with cryptogenic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.J. Gladstone" 1 => "M. Spring" 2 => "P. Dorian" 3 => "V. Panzov" 4 => "K.E. Thorpe" 5 => "J. Hall" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1311376" "Revista" => array:6 [ "tituloSerie" => "New Engl J Med" "fecha" => "2014" "volumen" => "370" "paginaInicial" => "2467" "paginaFinal" => "2477" "itemHostRev" => array:3 [ "pii" => "S1053811918302817" "estado" => "S300" "issn" => "10538119" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0370" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Embolic stroke of undetermined source: a systematic review and clinical update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.G. Hart" 1 => "L. Catanese" 2 => "K.S. Perera" 3 => "G. Ntaios" 4 => "S.J. Connolly" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.116.016414" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2017" "volumen" => "48" "paginaInicial" => "867" "paginaFinal" => "872" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28265016" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0375" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Parámetros ecocardiográficos de cardiopatía auricular y detección de fibrilación auricular en el ictus criptogénico" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Á. Lambea Gil" 1 => "H. Tejada Meza" 2 => "C.R. López Perales" 3 => "J. Artal Roy" 4 => "J. Marta Moreno" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nrl.2017.12.012" "Revista" => array:6 [ "tituloSerie" => "Neurología" "fecha" => "2018" "volumen" => "12" "paginaInicial" => "10" "paginaFinal" => "13" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9470432" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0380" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Embolic stroke of undetermined source and detection of atrial fibrillation on follow-up: how much causality is there" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Ntaios" 1 => "V. Papavasileiou" 2 => "G.Y.H. Lip" 3 => "H. Milionis" 4 => "K. Makaritsis" 5 => "A. Vemmou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jstrokecerebrovasdis.2016.08.015" "Revista" => array:6 [ "tituloSerie" => "J Stroke Cerebrovasc Dis" "fecha" => "2016" "volumen" => "25" "paginaInicial" => "2975" "paginaFinal" => "2980" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27612625" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0385" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of functional outcome and stroke recurrence in patients with embolic stroke of undetermined source (ESUS) vs Cardioembolic stroke patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Arauz" 1 => "E. Morelos" 2 => "J. Colín" 3 => "J. Roldán" 4 => "M.A. Barboza" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone. 0166091" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2016" "volumen" => "11" "paginaInicial" => "1" "paginaFinal" => "9" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0390" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Embolic strokes of undetermined source: prevalence and patient features in the ESUS global registry" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.S. Perera" 1 => "T. Vanassche" 2 => "J. Bosch" 3 => "M. Giruparajah" 4 => "B. Swaminathan" 5 => "K.R. Mattina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1747493016641967" "Revista" => array:5 [ "tituloSerie" => "Int J Stroke" "fecha" => "2016" "volumen" => "11" "paginaInicial" => "526" "paginaFinal" => "533" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0395" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Age- and sex-specific analysis of patients with embolic stroke of undetermined source" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Ntaios" 1 => "G.Y.H. Lip" 2 => "K. Vemmos" 3 => "E. Koroboki" 4 => "E. Manios" 5 => "A. Vemmou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL. 0000000000004199" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2017" "volumen" => "89" "paginaInicial" => "532" "paginaFinal" => "539" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28687720" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0400" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Infarto cerebral criptogénico en pacientes jóvenes. Pronóstico y recurrencia a largo plazo" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Arauz" 1 => "M. Merlos-Benítez" 2 => "L.F. Roa" 3 => "B. Hernández-Curiel" 4 => "C. Cantú" 5 => "L. Murillo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nrl.2010.10.010" "Revista" => array:6 [ "tituloSerie" => "Neurología" "fecha" => "2011" "volumen" => "26" "paginaInicial" => "279" "paginaFinal" => "284" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21354670" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0405" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk stratification for recurrence and mortality in embolic stroke of undetermined source" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Ntaios" 1 => "K. Vemmos" 2 => "G.Y.H. Lip" 3 => "E. Koroboki" 4 => "E. Manios" 5 => "A. Vemmou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.116.013713" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2016" "volumen" => "47" "paginaInicial" => "2278" "paginaFinal" => "2285" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27507859" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0410" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Avances en la prevención de la isquemia cerebral por fibrilación auricular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Gil Núñez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nrl.2010.03.008" "Revista" => array:6 [ "tituloSerie" => "Neurología" "fecha" => "2010" "volumen" => "25" "paginaInicial" => "401" "paginaFinal" => "408" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20964985" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0415" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.J. Powers" 1 => "A.A. Rabinstein" 2 => "T. Ackerson" 3 => "O.M. Adeoye" 4 => "N.C. Bambakidis" 5 => "K. Becker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STR.0000000000000158" "Revista" => array:3 [ "tituloSerie" => "Stroke" "fecha" => "2018" "volumen" => "49" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0420" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.N. Kernan" 1 => "B. Ovbiagele" 2 => "H.R. Black" 3 => "D.M. Bravata" 4 => "M.I. Chimowitz" 5 => "M.D. Ezekowitz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STR.0000000000000024" "Revista" => array:5 [ "tituloSerie" => "Stroke" "fecha" => "2014" "volumen" => "45" "paginaInicial" => "2136" "paginaFinal" => "2160" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0425" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Arritmias cardiacas en la unidad de ictus: análisis de los datos de la monitorización cardiaca" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Fernández-Menéndez" 1 => "R. García-Santiago" 2 => "A. Vega-Primo" 3 => "N. González Nafría" 4 => "L.B. Lara-Lezama" 5 => "L. Redondo-Robles" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nrl.2015.03.013" "Revista" => array:6 [ "tituloSerie" => "Neurología" "fecha" => "2016" "volumen" => "31" "paginaInicial" => "289" "paginaFinal" => "295" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25976944" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0430" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Embolic strokes of unknown source and cryptogenic stroke: implications in clinical practice" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Nouh" 1 => "M. Hussain" 2 => "T. Mehta" 3 => "S. Yaghi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fneur.2016.00037" "Revista" => array:5 [ "tituloSerie" => "Front Neurol" "fecha" => "2016" "volumen" => "7" "paginaInicial" => "37" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27047443" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0435" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Temporal relationship between subclinical atrial fibrillation and embolic events" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Brambatti" 1 => "S.J. Connolly" 2 => "M.R. Gold" 3 => "C.A. Morillo" 4 => "A. Capucci" 5 => "C. Muto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.113.007825" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2014" "volumen" => "129" "paginaInicial" => "2094" "paginaFinal" => "2099" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24633881" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0440" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atrial cardiopathy and cryptogenic stroke: a cross-sectional pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Yaghi" 1 => "A.K. Boehme" 2 => "R. Hazan" 3 => "E.A. Hod" 4 => "A. Canaan" 5 => "H.F. Andrews" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jstrokecerebrovasdis.2015.09.001" "Revista" => array:5 [ "tituloSerie" => "J Stroke Cerebrovasc Dis" "fecha" => "2015" "paginaInicial" => "1" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30539753" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0445" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electrocardiographic left atrial abnormality and risk of stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Kamel" 1 => "M. Hunter" 2 => "Y.P. Moon" 3 => "S. Yaghi" 4 => "K. Cheung" 5 => "M.R. Di Tullio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.115.009989" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2015" "volumen" => "46" "paginaInicial" => "3208" "paginaFinal" => "3212" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26396031" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0450" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Subclinical atrial fibrillation and the risk of stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.S. Healey" 1 => "S.J. Connolly" 2 => "M.R. Gold" 3 => "C.W. Israel" 4 => "I.C. Van Gelder" 5 => "A. Capucci" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1105575" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2012" "volumen" => "366" "paginaInicial" => "120" "paginaFinal" => "129" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22236222" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0455" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "P-Wave analysis in valvular heart disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => ".J.J. Morris" 1 => "E.H. Estes" 2 => "R.E. Whalen" 3 => "H.K. Thompson" 4 => "H.D. Mcintosh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.CIR.29.2.242" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1964" "volumen" => "29" "paginaInicial" => "242" "paginaFinal" => "252" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14119389" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0460" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence and prognostic significance of abnormal P terminal force in lead V 1 of the ECG in the general population" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Eranti" 1 => "A.L. Aro" 2 => "T. Kerola" 3 => "O. Anttonen" 4 => "H.A. Rissanen" 5 => "J.T. Tikkanen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCEP.114.001557" "Revista" => array:5 [ "tituloSerie" => "Circ Arrhythmia Electrophysiol" "fecha" => "2014" "volumen" => "7" "paginaInicial" => "1116" "paginaFinal" => "1121" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0465" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "P-wave morphology and the risk of incident ischemic stroke in the multi-ethnic study of atherosclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Kamel" 1 => "E.Z. Soliman" 2 => "S.R. Heckbert" 3 => "R.A. Kronmal" 4 => "W.T. Longstreth" 5 => "S. Nazarian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.114.006364" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2014" "volumen" => "45" "paginaInicial" => "2786" "paginaFinal" => "2788" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25052322" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0470" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interatrial blocks. A separate entity from left atrial enlargement: a consensus report" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Bayés de Luna" 1 => "P. Platonov" 2 => "F.G. Cosio" 3 => "I. Cygankiewicz" 4 => "C. Pastore" 5 => "R. Baranowski" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jelectrocard.2012.06.029" "Revista" => array:6 [ "tituloSerie" => "J Electrocardiol" "fecha" => "2012" "volumen" => "45" "paginaInicial" => "445" "paginaFinal" => "451" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22920783" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0475" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Di Biase" 1 => "P. Santangeli" 2 => "M. Anselmino" 3 => "P. Mohanty" 4 => "I. Salvetti" 5 => "S. Gili" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2012.04.032" "Revista" => array:5 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2012" "volumen" => "60" "paginaInicial" => "531" "paginaFinal" => "538" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0480" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Left atrial appendage morphology and embolic stroke of undetermined source: a cross-sectional multicenter pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Yaghi" 1 => "A.D. Chang" 2 => "P. Hung" 3 => "B. Mac Grory" 4 => "S. Collins" 5 => "A. Gupta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jstrokecerebrovasdis.2017.12.036" "Revista" => array:5 [ "tituloSerie" => "J Stroke Cerebrovasc Dis" "fecha" => "2018" "paginaInicial" => "1" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30539753" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0485" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relation between left atrial measurements and thromboembolic risk markers assessed by echocardiography in patients with nonvalvular atrial fibrillation: a cross-sectional study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H.I. Radwan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ehj.2016.05.004" "Revista" => array:5 [ "tituloSerie" => "Egypt Hear J" "fecha" => "2017" "volumen" => "69" "paginaInicial" => "1" "paginaFinal" => "11" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0490" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "N-terminal Pro–B-type natriuretic peptide, and incidence of stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.R. Folsom" 1 => "V. Nambi" 2 => "E.J. Bell" 3 => "O.W. Oluleye" 4 => "R.F. Gottesman" 5 => "P.L. Lutsey" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.111.000173" "Revista" => array:5 [ "tituloSerie" => "Stroke" "fecha" => "2013" "volumen" => "44" "paginaInicial" => "961" "paginaFinal" => "967" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0495" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between troponin levels and embolic stroke of undetermined source" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.E. Merkler" 1 => "G. Gialdini" 2 => "S.B. Murthy" 3 => "S. Salehi Omran" 4 => "A. Moya" 5 => "M.P. Lerario" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/JAHA.117.005905" "Revista" => array:5 [ "tituloSerie" => "J Am Heart Assoc" "fecha" => "2017" "volumen" => "6" "paginaInicial" => "e005905" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28939703" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0500" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Rodriguez-Yanez" 1 => "S. Arias-Rivas" 2 => "M. Santamaria-Cadavid" 3 => "T. Sobrino" 4 => "J. Castillo" 5 => "M. Blanco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0b013e31829d8773" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2013" "volumen" => "81" "paginaInicial" => "444" "paginaFinal" => "447" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23803318" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0505" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E. Hanson" 1 => "K. Jood" 2 => "S. Karlsson" 3 => "S. Nilsson" 4 => "C. Blomstrand" 5 => "C. Jern" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1538-7836.2010.04134.x" "Revista" => array:6 [ "tituloSerie" => "J Thromb Haemost" "fecha" => "2011" "volumen" => "9" "paginaInicial" => "275" "paginaFinal" => "281" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21781264" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0510" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevención del ictus en la fibrilación auricular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J. Masjuan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0213-4853(12)70001-4" "Revista" => array:7 [ "tituloSerie" => "Neurología" "fecha" => "2012" "volumen" => "27" "numero" => "Supl 1" "paginaInicial" => "1" "paginaFinal" => "3" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22682203" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0515" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "V. atrial cardiopathy: a mechanism of cryptogenic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Yaghi" 1 => "H. Kamel" 2 => "M.S. Elkind" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/14779072.2017.1355238" "Revista" => array:6 [ "tituloSerie" => "Expert Rev Cardiovasc Ther" "fecha" => "2017" "volumen" => "15" "paginaInicial" => "591" "paginaFinal" => "599" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28718666" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0520" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atrial cardiomyopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Guichard" 1 => "S. Nattel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2017.06.033" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2017" "volumen" => "70" "paginaInicial" => "756" "paginaFinal" => "765" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28774383" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0525" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: the PRIMERI Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Tiffany Win" 1 => "B. Ambale Venkatesh" 2 => "G.J. Volpe" 3 => "N. Mewton" 4 => "P. Rizzi" 5 => "R.K. Sharma" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.hrthm.2014.09.044" "Revista" => array:5 [ "tituloSerie" => "Hear Rhythm" "fecha" => "2015" "volumen" => "12" "paginaInicial" => "155" "paginaFinal" => "162" ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0530" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Kamel" 1 => "T.M. Bartz" 2 => "W.T. Longstreth" 3 => "P.M. Okin" 4 => "E.L. Thacker" 5 => "K.K. Patton" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.114.007762" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2015" "volumen" => "46" "paginaInicial" => "711" "paginaFinal" => "716" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25677594" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0535" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.V. Glotzer" 1 => "E.G. Daoud" 2 => "D.G. Wyse" 3 => "D.E. Singer" 4 => "M.D. Ezekowitz" 5 => "C. Hilker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCEP.109.849638" "Revista" => array:5 [ "tituloSerie" => "Circ Arrhythmia Electrophysiol" "fecha" => "2009" "volumen" => "2" "paginaInicial" => "474" "paginaFinal" => "480" ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0540" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.D. Ziegler" 1 => "T.V. Glotzer" 2 => "E.G. Daoud" 3 => "D.E. Singer" 4 => "M.D. Ezekowitz" 5 => "R.H. Hoyt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2012.06.034" "Revista" => array:5 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2012" "volumen" => "110" "paginaInicial" => "1309" "paginaFinal" => "1314" ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0545" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.G. Daoud" 1 => "T.V. Glotzer" 2 => "D.G. Wyse" 3 => "M.D. Ezekowitz" 4 => "C. Hilker" 5 => "J. Koehler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.hrthm.2011.04.022" "Revista" => array:5 [ "tituloSerie" => "Hear Rhythm" "fecha" => "2011" "volumen" => "8" "paginaInicial" => "1416" "paginaFinal" => "1423" ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0550" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of interatrial block with development of atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Y.K. Agarwal" 1 => "W.S. Aronow" 2 => "J.A. Levy" …1 ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0002-9149(03)00027-4" "Revista" => array:5 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2003" "volumen" => "91" "paginaInicial" => "882" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0555" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/oxfordjournals.eurheartj.a062407" "Revista" => array:5 [ "tituloSerie" => "Eur Heart J" "fecha" => "1988" "volumen" => "9" "paginaInicial" => "1112" "paginaFinal" => "1118" ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0560" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1755-5922.12063" "Revista" => array:7 [ "tituloSerie" => "Cardiovasc Ther" "fecha" => "2014" "volumen" => "32" "paginaInicial" => "52" "paginaFinal" => "56" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0896627318307414" "estado" => "S300" "issn" => "08966273" ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0565" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advanced interatrial block is associated with atrial fibrillation recurrence after successful pulmonary vein isolation for paroxysmal atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10840-013-9851-1" "Revista" => array:6 [ "tituloSerie" => "J Interv Card Electrophysiol" "fecha" => "2014" "volumen" => "39" "paginaInicial" => "131" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0570" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "New-onset atrial fibrillation after cavotricuspid isthmus ablation: identification of advanced interatrial block is key" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/europace/euu379" "Revista" => array:6 [ "tituloSerie" => "Europace" "fecha" => "2015" "volumen" => "17" "paginaInicial" => "1289" "paginaFinal" => "1293" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0575" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advanced interatrial block predicts new onset atrial fibrillation in patients with severe heart failure and cardiac resynchronization therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/anec.12258" "Revista" => array:6 [ "tituloSerie" => "Ann Noninvasive Electrocardiol" "fecha" => "2015" "volumen" => "20" "paginaInicial" => "586" "paginaFinal" => "591" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0580" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advanced interatrial block as a key marker for atrial fibrillation recurrence: Bayés’ syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.11909/j.issn.1671-5411.2017.03.005" "Revista" => array:6 [ "tituloSerie" => "J Geriatr Cardiol" "fecha" => "2017" "volumen" => "14" "paginaInicial" => "169" "paginaFinal" => "173" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0585" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bayés syndrome and acute cardioembolic ischemic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.12998/wjcc.v5.i3.93" "Revista" => array:5 [ "tituloSerie" => "World J Clin Cases" "fecha" => "2017" "volumen" => "5" "paginaInicial" => "93" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0590" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interatrial block in the modern era" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2174/1573403X10666140514101748" "Revista" => array:6 [ "tituloSerie" => "Curr Cardiol Rev" "fecha" => "2014" "volumen" => "10" "paginaInicial" => "181" "paginaFinal" => "189" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0595" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advanced interatrial block and ischemic stroke: the atherosclerosis risk in communities study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0000000000002888" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2016" "volumen" => "87" "paginaInicial" => "352" "paginaFinal" => "356" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0600" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.hrthm.2013.10.020" "Revista" => array:5 [ "tituloSerie" => "Hear Rhythm" "fecha" => "2014" "volumen" => "11" "paginaInicial" => "2" "paginaFinal" => "7" ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0605" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Annals of internal medicine accuracy of transesophageal echocardiography for identifying left atrial thrombi" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Surgery" "fecha" => "1995" "volumen" => "123" "paginaInicial" => "817" "paginaFinal" => "822" ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0610" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patients with undetermined stroke have increased atrial fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.117.019641" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2018" "volumen" => "49" "paginaInicial" => "734" "paginaFinal" => "737" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0615" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2010.1768" "Revista" => array:5 [ "tituloSerie" => "JAMA" "fecha" => "2010" "volumen" => "304" "paginaInicial" => "2503" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0620" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elevated troponin after stroke: a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000226773" "Revista" => array:6 [ "tituloSerie" => "Cerebrovasc Dis" "fecha" => "2009" "volumen" => "28" "paginaInicial" => "220" "paginaFinal" => "226" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0625" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.114.007858" "Revista" => array:5 [ "tituloSerie" => "Stroke" "fecha" => "2015" "volumen" => "46" "paginaInicial" => "1132" "paginaFinal" => "1140" ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0630" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronary angiographic findings in acute ischemic stroke patients with elevated cardiac troponin: the troponin elevation in acute ischemic stroke (TRELAS) study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.115.018547" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2016" "volumen" => "133" "paginaInicial" => "1264" "paginaFinal" => "1271" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0635" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amino-terminal Pro–B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/HYPERTENSIONAHA.109.143313" "Revista" => array:5 [ "tituloSerie" => "Hypertension" "fecha" => "2010" "volumen" => "55" "paginaInicial" => "785" "paginaFinal" => "791" ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0640" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "N-terminal Pro–B-type natriuretic peptide and stroke risk" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.114.004712" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2014" "volumen" => "45" "paginaInicial" => "1646" "paginaFinal" => "1650" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0645" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma natriuretic peptides and incidence of subtypes of ischemic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000363279" "Revista" => array:6 [ "tituloSerie" => "Cerebrovasc Dis" "fecha" => "2014" "volumen" => "37" "paginaInicial" => "444" "paginaFinal" => "450" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0650" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.114.008311" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2015" "volumen" => "46" "paginaInicial" => "1187" "paginaFinal" => "1195" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0655" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ahj.2018.07.008" "Revista" => array:5 [ "tituloSerie" => "Am Heart J" "fecha" => "2018" "volumen" => "204" "paginaInicial" => "119" "paginaFinal" => "127" ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0660" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Exp Clin Cardiol" "fecha" => "2004" "volumen" => "9" "paginaInicial" => "31" "paginaFinal" => "34" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0665" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for ischemic stroke subtypes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.STR. 0000239694.19359.88" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2006" "volumen" => "37" "paginaInicial" => "2493" "paginaFinal" => "2498" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0670" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Von Willebrand factor: multimeric structure and functional activity in patients with atrial fibrillation with and without oral anticoagulation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1076029617711803" "Revista" => array:5 [ "tituloSerie" => "Clin Appl Thromb" "fecha" => "2018" "volumen" => "24" "paginaInicial" => "647" "paginaFinal" => "654" ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0675" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High von Willebrand factor levels increase the risk of stroke: the Rotterdam study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.110.586289" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2010" "volumen" => "41" "paginaInicial" => "2151" "paginaFinal" => "2156" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0680" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Canadian Stroke best practice recommendations: secondary prevention of stroke guidelines, update 2014" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ijs.12439" "Revista" => array:6 [ "tituloSerie" => "Int J Stroke" "fecha" => "2015" "volumen" => "10" "paginaInicial" => "282" "paginaFinal" => "291" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0685" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rivaroxaban for stroke prevention after embolic stroke of undetermined source" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1802686" "Revista" => array:5 [ "tituloSerie" => "N Engl J Med" "fecha" => "2018" "volumen" => "378" "paginaInicial" => "2191" "paginaFinal" => "2201" ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0690" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Design of randomized, double-blind, evaluation in secondary stroke prevention comparing the efficacy and safety of the oral thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT ESUS)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ijs.12630" "Revista" => array:6 [ "tituloSerie" => "Int J Stroke" "fecha" => "2015" "volumen" => "10" "paginaInicial" => "1309" "paginaFinal" => "1312" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0695" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1747493018799981" "Revista" => array:2 [ "tituloSerie" => "Int J Stroke" "fecha" => "2018" ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0700" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Secondary stroke prevention in cryptogenic stroke and embolic stroke of undetermined source (ESUS)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11910-017-0775-5" "Revista" => array:6 [ "tituloSerie" => "Curr Neurol Neurosci Rep" "fecha" => "2017" "volumen" => "17" "paginaInicial" => "17" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735808/0000003700000005/v1_202206050515/S2173580821000596/v1_202206050515/en/main.assets" "Apartado" => array:4 [ "identificador" => "9423" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735808/0000003700000005/v1_202206050515/S2173580821000596/v1_202206050515/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580821000596?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 12 | 3 | 15 |
2024 October | 45 | 12 | 57 |
2024 September | 72 | 11 | 83 |
2024 August | 72 | 8 | 80 |
2024 July | 42 | 4 | 46 |
2024 June | 27 | 16 | 43 |
2024 May | 39 | 19 | 58 |
2024 April | 39 | 3 | 42 |
2024 March | 61 | 15 | 76 |
2024 February | 66 | 23 | 89 |
2024 January | 43 | 22 | 65 |
2023 December | 66 | 10 | 76 |
2023 November | 46 | 23 | 69 |
2023 October | 58 | 17 | 75 |
2023 September | 30 | 14 | 44 |
2023 August | 27 | 11 | 38 |
2023 July | 47 | 10 | 57 |
2023 June | 43 | 9 | 52 |
2023 May | 73 | 19 | 92 |
2023 April | 50 | 10 | 60 |
2023 March | 34 | 16 | 50 |
2023 February | 33 | 23 | 56 |
2023 January | 38 | 28 | 66 |
2022 December | 40 | 218 | 258 |
2022 November | 51 | 60 | 111 |
2022 October | 32 | 21 | 53 |
2022 September | 48 | 21 | 69 |
2022 August | 51 | 11 | 62 |
2022 July | 36 | 18 | 54 |
2022 June | 49 | 16 | 65 |
2022 May | 21 | 25 | 46 |
2022 April | 18 | 25 | 43 |
2022 March | 26 | 24 | 50 |
2022 February | 13 | 8 | 21 |
2022 January | 17 | 16 | 33 |
2021 December | 21 | 16 | 37 |
2021 November | 20 | 24 | 44 |
2021 October | 29 | 25 | 54 |
2021 September | 23 | 36 | 59 |
2021 August | 30 | 10 | 40 |
2021 July | 14 | 12 | 26 |
2021 June | 18 | 7 | 25 |
2021 May | 15 | 4 | 19 |
2021 April | 0 | 2 | 2 |